Case study: Precision analytics to overhaul HCP target list for hem onc drug launch

Current data and analytics capabilities are often times insufficient to identify and characterize precise patient cohorts and prescribers for targeted therapies. Learn how Clarify Health aided the launch of a second-line therapeutic in Acute Myeloid Leukemia (AML), and revamped this top pharma’s HCP target list to significantly increase the revenue potential of the product.

Download the Case Study

Download Now